Blue Buffalo Announces Third Quarter 2017 Earnings Conference Call
Oct 16, 2017 17:40 pm UTC| Business
WILTON, Conn., Oct. 16, 2017 -- Wilton based Blue Buffalo Pet Products, Inc. (Nasdaq:BUFF) will release its financial results for third quarter 2017 after the market closes on Tuesday November 7, 2017. The company...
Against All Odds – College Degree To Prime Minister
Oct 16, 2017 17:37 pm UTC| Business
CINCINNATI, OH, Oct. 16, 2017 -- The Most Honorable Portia Simpson Miller will keynote Union Institute University National Commencement Ceremony on Saturday, October 28, 2017 at 11 a.m. at the Hilton Netherland Plaza...
Oct 16, 2017 17:25 pm UTC| Business
KANSAS CITY, Mo., Oct. 16, 2017 -- Caravan Health’s Accountable Care Organization (ACO) clients saved more than $26 million across approximately 250,000 covered lives in 2016, based on a Centers for Medicare and...
Oct 16, 2017 17:21 pm UTC| Business
TAMPA, Fla., Oct. 16, 2017 -- Twenty hospitalists from 18 Adventist Health System facilities around the nation are now better equipped to solve problems such as lengthy patient stays, rate of readmission, and sepsis....
Educational Development Corporation Announces Second Quarter Fiscal 2018 Results
Oct 16, 2017 17:16 pm UTC| Business
TULSA, Okla., Oct. 16, 2017 -- Educational Development Corporation (“EDC”) (NASDAQ:EDUC) (http://www.edcpub.com) today reports record net sales and earnings per share results for the second quarter ended August 31,...
GhangorCloud Wins 2017 Data Leak Prevention Solution of the Year Award
Oct 16, 2017 17:12 pm UTC| Business
SAN JOSE, Calif., Oct. 16, 2017 -- GhangorCloud has received the 2017 Data Leak Prevention Solution of the Year award from Computing Security. This is the second year in a row that the GhangorCloud Information Security...
BioMarin Pharmaceutical, Inc. (Nasdaq: BMRN) to Ring The Nasdaq Stock Market Closing Bell
Oct 16, 2017 17:07 pm UTC| Business
ADVISORY, Oct. 16, 2017 -- What: BioMarin Pharmaceutical, Inc. (Nasdaq:BMRN), a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes, will visit...